The lack of NF-κB activity in most GCB-DLBCL seemingly contrasts with the frequent occurrence of REL gene amplifications [111], which has long been recognized as a defining genetic feature of this molecular subtype (15–30% of cases, vs. 5% of ABC DLBCLs) [112]. The gene discussed is NFKB1; the disease is aneurysmal bone cyst.